Who Exports Chlorambucil from India — 109 Suppliers Behind a $343.6K Market
India's chlorambucil export market is supplied by 109 active exporters who collectively shipped $343.6K across 325 shipments. CELON LABORATORIES PRIVATE LIMITED leads with a 25.5% market share, followed by INFUGEN PHARMA PRIVATE LIMITED and SP ACCURE LABS PRIVATE LIMITED. The top 5 suppliers together control 57.8% of total export value, reflecting a moderately competitive market structure.
Top Chlorambucil Exporters from India — Ranked by Export Value
CELON LABORATORIES PRIVATE LIMITED is the leading chlorambucil exporter from India, holding a 25.5% share of the $343.6K market across 325 shipments from 109 exporters. The top 5 suppliers — CELON LABORATORIES PRIVATE LIMITED, INFUGEN PHARMA PRIVATE LIMITED, SP ACCURE LABS PRIVATE LIMITED, GLS PHARMA LIMITED, DECINA PHARMA PRIVATE LIMITED — collectively control 57.8% of total export value, indicating a moderately concentrated market. Individual shares are: CELON LABORATORIES PRIVATE LIMITED (25.5%), INFUGEN PHARMA PRIVATE LIMITED (22.1%), SP ACCURE LABS PRIVATE LIMITED (4.7%), GLS PHARMA LIMITED (3.6%), DECINA PHARMA PRIVATE LIMITED (2.0%).
Top Chlorambucil Exporters from India
Ranked by export value · 109 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | CELON LABORATORIES PRIVATE LIMITED CELKERAN 2 CHLORAMBUCIL TABLETS 2MGCELKERAN 2 CHLORAMBUCIL TABLETS USP 2MGCELKERAN 2 CHLORAMBUCIL TABLETS USP 2MG2757NOS4.86 | $87.5K | 6 | 25.5% |
| 2 | INFUGEN PHARMA PRIVATE LIMITED PHARMACEUTICAL PRODUCTS: CHLORAMBUCIL TABLETS USP 2MGCHLORAMBUCIL 2MGHALKERAN 2PHARMACEUTICAL PRODUCTS: LEUKOBUCIL 2MG | $75.9K | 1 | 22.1% |
| 3 | SP ACCURE LABS PRIVATE LIMITED CHLORAMBUCIL TABLETS 2MGCHLORAMBUCIL TABLETS 2 MGCHLORAMBUCIL 2MG TABLETS 30 S, | $16.0K | 1 | 4.7% |
| 4 | GLS PHARMA LIMITED CHLORAMBUCIL 2MGHALKERAN 2CHLORAMAX 2MG TABLETCHLORAMAX 2MG TAB CHLORAMBUCIL 2MG TAB | $12.3K | 2 | 3.6% |
| 5 | DECINA PHARMA PRIVATE LIMITED CHLORAMBUCIL 2MGHALKERAN 2PHARMACEUTICAL PRODUCTS: LEUKOBUCIL 2MGCHLORAMBUCIL 2MG/TAB | $6.8K | 1 | 2.0% |
| 6 | BRUCK PHARMA PRIVATE LIMITED | $4.8K | 1 | 1.4% |
| 7 | 3S PHARMACEUTICALS INDIA PRIVATE LIMITED CHLORAMBUCIL 2MG TABLETS 30 S,CHLORAMBUCIL 2MG TABLETS/CHLORAMBUCIL 2MG TABLETS CELKERAN 2 MG 30 S | $4.1K | 4 | 1.2% |
| 8 | ARADHYA INTERNATIONAL CHLORAMBUCIL 2MG TABLETS 30 S,CHLORAMBUCIL 2MG TABLETS/CHLORAMBUCIL 2MG TABLETS CELKERAN 2 MG 30 S | $3.8K | 1 | 1.1% |
| 9 | EXSELL LABORATORIES PRIVATE LIMITED | $3.3K | 1 | 1.0% |
| 10 | ROYAL MEDICAL PRIVATE LIMITED | $3.2K | 2 | 0.9% |
| 11 | MDS ENTERPRISES | $3.0K | 3 | 0.9% |
| 12 | S. HIMATLAL HEALTHCARE LLP CHLORAMBUCIL 2MG TABLET EACH TABLET OF CCHLORAMBUCIL TABLETS BP 2MGLEUKOBUCIL 2MG | $2.9K | 1 | 0.8% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Chlorambucil exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| CELON LABORATORIES PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| INFUGEN PHARMA PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| SP ACCURE LABS PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| GLS PHARMA LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| DECINA PHARMA PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| BRUCK PHARMA PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| 3S PHARMACEUTICALS INDIA PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| ARADHYA INTERNATIONAL | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| EXSELL LABORATORIES PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
| ROYAL MEDICAL PRIVATE LIMITED | Not Listed | Yes, as of January 2 | No | Not verified | WHO-GMP certification confirmed by CDSCO. |
TransData Nexus reviewed the regulatory standing of 10 leading Chlorambucil exporters from India. 0 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Chlorambucil sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts numerous pharmaceutical companies, including CELON LABORATORIES PRIVATE LIMITED, a leading exporter of Chlorambucil, accounting for 25.5% of total exports. Hyderabad's robust infrastructure and supportive policies have fostered a conducive environment for API production, making it a critical node in the supply chain for oncology drugs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region is home to major companies like Alembic Pharmaceuticals and Zydus Lifesciences, which specialize in the development and manufacturing of finished dosage forms. The presence of such companies underscores the region's capacity for producing high-quality pharmaceutical formulations, including those for oncology treatments.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a significant export gateway for Indian pharmaceuticals. Mumbai, being a major port city, facilitates the global distribution of pharmaceutical products. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, leverage this strategic location to export a wide range of medications, including oncology drugs, to international markets. The region's well-established logistics and regulatory framework support efficient export operations.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing zone, primarily due to favorable tax incentives and supportive government policies. This region attracts numerous pharmaceutical companies seeking cost-effective production solutions. The cluster's growth has contributed significantly to India's pharmaceutical output, including the manufacturing of various oncology drugs.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and compliance records of potential suppliers to ensure consistent quality and regulatory adherence.
- Leverage Export Hubs: Utilize the logistical advantages of export-oriented clusters like Mumbai-Thane-Raigad for efficient global distribution.
- Monitor Regulatory Changes: Stay informed about policy shifts in tax incentive zones such as Baddi-Nalagarh to capitalize on cost-saving opportunities.
By strategically analyzing and engaging with India's pharmaceutical clusters, companies can optimize their supply chain for Chlorambucil and other critical medications.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Chlorambucil exporters from India
CELON LABORATORIES PRIVATE LIMITED — ZNZ Pharma acquires 74% stake in Celon Labs for Rs 364 crore
ZNZ Pharma 2, backed by the UK's CDC Group, Development Partners International, and the European Bank for Reconstruction and Development, acquired a 74% stake in Celon Laboratories for Rs 364 crore. An additional investment of approximately Rs 200 crore is planned to establish a new manufacturing facility in Hyderabad, aiming to cater to regulated markets globally. - IMPACT: The acquisition and planned facility expansion are expected to enhance Celon Labs' production capacity and regulatory compliance, potentially increasing Chlorambucil exports.
Impact: The acquisition and planned facility expansion are expected to enhance Celon Labs' production capacity and regulatory compliance, potentially increasing Chlorambucil exports.
CELON LABORATORIES PRIVATE LIMITED — IQuest Enterprises acquires Viatris' API business, including Celon Labs
IQuest Enterprises, promoted by Nimmagadda Prasad's family, acquired Viatris' active pharmaceutical ingredients (API) business, which includes Celon Laboratories. The acquisition encompasses multiple manufacturing sites and an R&D laboratory in Hyderabad, as well as facilities in Visakhapatnam. (synapse-patsnap-com.libproxy1.nus.edu.sg) - IMPACT: This acquisition is likely to bolster Celon Labs' API production capabilities, potentially leading to increased Chlorambucil exports.
Impact: This acquisition is likely to bolster Celon Labs' API production capabilities, potentially leading to increased Chlorambucil exports.
CELON LABORATORIES PRIVATE LIMITED — Celon Labs receives manufacturing license for tablets, capsules, and injections
The Drugs Control Administration of Telangana granted Celon Laboratories Limited a manufacturing license (Form 25 and Form 28) for tablets, capsules, and injections at their facility in Gajularamaram, Medchal District. - IMPACT: The regulatory approval enables Celon Labs to expand its product offerings, potentially increasing Chlorambucil production and exports.
Impact: The regulatory approval enables Celon Labs to expand its product offerings, potentially increasing Chlorambucil production and exports.
Common Questions — Chlorambucil Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which chlorambucil supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, CELON LABORATORIES PRIVATE LIMITED leads with 18 recorded shipments worth $87.5K. INFUGEN PHARMA PRIVATE LIMITED (3 shipments) and SP ACCURE LABS PRIVATE LIMITED (3 shipments) are also established high-volume exporters.
Q How many chlorambucil manufacturers are there in India?
India has 109 active chlorambucil exporters with a combined export market of $343.6K across 325 shipments to 60 countries. The top 5 suppliers hold 57.8% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for chlorambucil from India?
Average FOB unit price: $12.59 per unit, ranging from $0.08 to $320.04. Average shipment value: $1.1K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 109 verified Indian exporters of Chlorambucil ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 325 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 60 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
325 Verified Shipments
109 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists